Small Cap Research
Small Cap Biotech Screens Attractive in the GI Space
Phathom (PHAT) is a small cap Biotech that is showing relative strength and has seen more than 4000 each of the February $10 and $12.50 calls buy that remain in open interest at a small profit. PHAT shares are +80% YTD nearing the top-end of a three year range. PHAT...
Unusual Calls Bought in Test & Inspection Leader
TIC Solutions (TIC) with an unusual buy of 1000 June $12.50 calls for $1.75 on 11/12, and also notice March $15 call open interest at over 7000X, looking back action started on 9/18 with buyers $1.65 to $2 and steady accumulation ever since. TIC started trading in...
Size Calls Bought in Eyewear Leader
Warby Parker (WRBY) saw unusual call buys on 11/6 with 2000 March $20 and 4200 June $22.50 bought and then on 11/12 massive action as 9500 December 2026 $25 calls bought. WRBY shares are -28% YTD and last week touched its long-term VPOC support and two-year trend...
Small Cap AI Infrastructure Provider Sees Bulls Position for Rally
Small Cap Options Flow WhiteFiber (WYFI) is a small cap provider of AI infrastructure solutions and has seen repeat bullish options flow continue recently as it pulls back to test its AVWAP from its IPO back in August. That level of support sits at 24.50 and held so...
Opening Put Seller Shows Confidence in Biotech Focused on Early Cancer Detection
Small Cap Options Flow GRAIL (GRAL) is a small cap biotech that has been a top winner in 2025 and formed a bull reversal candle Friday with markets rebounding and saw a massive bull sell to open 600 January 2027 $80 ITM puts for $28.50, collecting over $1.7M in...
Attractive Biotech M&A Target Sees Calls Accumulate
Abivax (ABVX) a Biotech with 2000 each November $90 and $100 calls bought in open interest and last week saw 600 each of the December $95 and $100 calls buy. ABVX also has 800 February $90 calls in open interest with 500+ from 10/6 trades that sold to open 15.50 to...
Option Bulls Take Notice of Pediatric Cancer Commercial Launch Growth Story
Day One (DAWN) shares surged last week yet are still -23% YTD. Options action picked up late in the week with 1500 January $10 bull synthetics, 7500 November $7 calls bought and size buys in December $8 and $9 calls. DAWN is now into a large weekly volume pocket with...
Capital-Light Oil Services Technology Small Cap Attractively Valued into Margin Expansion Period
Innovex Internation (INVX) is a name that reported results last week that caught my eye with a large beat of estimates and shares +43% YTD. INVX faded off highs with market weakness which was also right at the 200-week EMA. Innovex International is a rapidly growing...
Skilled Nursing Facility Provider with Unusual Call Accumulation Amid Industry Consolidation
PACS Group (PACS) has recently seen some unusual action with 1,275 far OTM January 2027 $25 calls bought at $2.50 on 11/6 following buyers in November $10 and $12.50 calls and has 5000 January 2027 $15 calls in open interest from aggressive buyers on 9/17 and 9/26....
Call Spread Targets Upside in Gene Editing Play
Beam Therapeutics (BEAM) with an interesting trade on 11/4 as 5000 February $25/$35 call spreads bought to open. BEAM shares are now -7% YTD after falling more than 30% off its October highs. Short interest at 20.8% of the float remains quite high. BEAM this week is...